| Japanese |
|---|
| Title | 99mTcスズコロイド肝スキャンにて肺描画を示した症例の分析 |
|---|
| Subtitle | 原著 |
|---|
| Authors | 白土博樹*, 伊藤和夫*, 斎藤知保子**, 種田雅彦***, 小柴隆蔵**, 古舘正従*, 入江五朗* |
|---|
| Authors(kana) | |
|---|
| Organization | *北海道大学医学部放射線科, **市立札幌病院放射線科, ***北海道大学医学部第二病理学教室 |
|---|
| Journal | 核医学 |
|---|
| Volume | 20 |
|---|
| Number | 6 |
|---|
| Page | 823-829 |
|---|
| Year/Month | 1983/7 |
|---|
| Article | 原著 |
|---|
| Publisher | 日本核医学会 |
|---|
| Abstract | 「要旨」スズコロイドを用いた肝スキャンでは, 時に肺が描出されることがある. この肺描出を示した症例の疾患の分析と肺描出を与える臨床的要因について検討した. 対象とした肝スキャンは3,460例で, 113回 (3.2%) に肺の描出が示された. 同一バイアルにて複数例が検査されており, 基準に合致した51スキャン41症例が対象となった. さらに, 肺描出を示さない49症例を核医学検査のコンピュータ登録データより抽出し, 同群 (対照群) との死亡率の相異について検討した. 肺描出群は, 対照群に比して短期 (30日) 死亡率が高く, 肝スキャンでの肺描出は予後不良の兆候といえる. しかし, 肺描出の程度や罹患疾患によっては臨床的重要性は異なることが示された. また臨床検査データと肺描出程度に関しては, コリンエステラーゼ低値率に相関が示された. |
|---|
| Practice | 臨床医学：一般 |
|---|
| Keywords | liver scan, 99mTc-Sn-colloid, lung uptake |
|---|
| English |
|---|
| Title | Clinical Evaluation of Lung Uptake on Liver Scan with Tc-99m Sn Colloid |
|---|
| Subtitle | Original Articles |
|---|
| Authors | Hiroki SHIRATO*, Kazuo ITOH*, Chihoko SAITO**, Masahiko TANEDA***, Ryuzo KOSHIBA**, Masayori FURUDATE*, Goro IRIE* |
|---|
| Authors(kana) | |
|---|
| Organization | *Department of Radiology Hokkaido University, **Department of Radiology Sapporo General Hospital, ***Second Department of Pathology Hokkaido University |
|---|
| Journal | The Japanese Journal of nuclear medicine |
|---|
| Volume | 20 |
|---|
| Number | 6 |
|---|
| Page | 823-829 |
|---|
| Year/Month | 1983/7 |
|---|
| Article | Original article |
|---|
| Publisher | THE JAPANESE SOCIETY OF NUCLEAR MEDICINE |
|---|
| Abstract | [Summary] The lung uptake has occasionally been noticed on the liver scan with 99mTc-Sn-colloid. In this paper clinical factors affecting lung uptake were discussed. One hundred and thirteen (3.2%) of 3460 scans showed the lung uptake. Fifty-one scans out of 41 patients (positive group) were further selected according to the criteria which were made for excluding unreliable factors such as poor labeling. As a control group, 49 scans out of 49 patients were sampled at randum from the computer date file of the nuclear medicine. The positive scans were most noted in patients with malignant diseases. However, there is no statistically significant difference between the positive and control group in the percentage of malignant diseases. In survival rate at 30 days after the liver scan, a statistical difference was shown between these groups. A severity of the lung uptake was well related to the serum colinesterase, but not to transaminase, BUN, chest X-ray, and liver abnormal findings on the scan. A positive scan seems to indicate poor prognosis if the patient with malignant disease shows a moderate or marked lung uptake. If with nonmalignancy or uptake was mild, the positive scan had not prognostic reliance. |
|---|
| Practice | Clinical medicine |
|---|
| Keywords | liver scan, 99mTc-Sn-colloid, lung uptake |
|---|